Have a personal or library account? Click to login
Antiviral Combination Approach as a Perspective to Combat Enterovirus Infections Cover

Antiviral Combination Approach as a Perspective to Combat Enterovirus Infections

PRILOZI
Volume 36 (2015): Issue 2 (December 2015)
By: Angel S. Galabov,  Ivanka Nikolova,  Ralitsa Vassileva-Pencheva and  Adelina Stoyanova  
Open Access
|Dec 2015

References

  1. Abzug MJ, Cloud G, Bradley J, Sanchez PJ, Romero J, Powell D, et al. Double blind placebo-controlled trial of pleconaril in inmfants with enterovirus meningitis. Pediatr Infect Dis. 2003; 36: 1523-1532.
    Search in Google Scholar
  2. Aitken C, Jeffries DJ Nosocomial spread of viral disease. Clinical Microbiology Review. 2001; 14: 528-546.10.1128/CMR.14.3.528-546.2001
    Search in Google Scholar
  3. Archard LC, Richardson PJ, Olsen EG, Dubowitz V, Sewry C, Bowles NE. The role of coxsackie B viruses in the pathogenesis of myocarditis, dilated cardiomyopathy and inflammatory muscle disease. Biochem Soc Symp. 1987; 53: 51-62.
    Search in Google Scholar
  4. Aradottir E., Alonso EM, Shulman ST. Severe neonatal enteroviral hepatitis treated with plrconaril. Pediatr Infect Dis. 2001; 20: 457-459.10.1097/00006454-200104000-00022
    Search in Google Scholar
  5. Chuang JH. (Enterovirus surveillance may be insufficient for estimating burden in Taiwan. Presented at: 14th International Congress on Infectious Diseases, March 9-12th, 2010; Miami, USA. Poster #40.005. 2010.
    Search in Google Scholar
  6. Diana GD, Rudewicz P., Pevear DC, Nitz TJ, Aldous SC, Robinson DT, et al. Picornavirus inhibitors: Trifluromethyl substitution provides a global protective effect against hepatic metabolism. J Med Chem. 1995; 38: 1355-1371.10.1021/jm00008a014
    Search in Google Scholar
  7. Galabov AS, Angelova A. Antiviral agents in the prevention and treatment of virus-induced diabetes. Anti-Infective Agents in Medicinal Chemistry. 2006; 5: 293-307.10.2174/187152106777697826
    Search in Google Scholar
  8. Hayden FG, Herrington DT, Coats TL, Kim K, Cooper EC, Villano SA, et al. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: Results of 2 double-blind, randomized, placebo- controlled trials. Clin Inf Dis. 2003; 36: 1523-1532.10.1086/375069
    Search in Google Scholar
  9. Herrmann EC Jr, Herrmann JA. A working hypothesis - virus resistance development as an indicator of specific antiviral activity. Ann NY Acad Sci. 1977; 284: 632-637.10.1111/j.1749-6632.1977.tb21997.x
    Search in Google Scholar
  10. Herrmann EC Jr, Herrmann JA, DeLong DC. Prevention of death in mice infected with coxsackievirus A16 using guanidine HCl mixed with substituted benzimidazoles. Antiviral Res. 1982; 2: 339-346.10.1016/0166-3542(82)90003-1
    Search in Google Scholar
  11. Hyoty H, Taylor KW. The role of viruses in human diabetes. Diabetologia. 2002; 45: 1353-136110.1007/s00125-002-0852-3
    Search in Google Scholar
  12. Loddo B. Development of drug resistance and dependence in viruses. Pharm Ther. 1980; 10: 431-46010.1016/0163-7258(80)90026-1
    Search in Google Scholar
  13. Mallia P, Contoli M, Caramori G, Pandit A, Johnston SL, Papi A. Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations. Current pahrmaceutical Design. 2007; 13: 73-97.10.2174/13816120777931377717266589
    Search in Google Scholar
  14. Melnick JL, Crowther D, Barrera-Oro J. Rapid development of drug-resistant mutants of poliovirus. Science. 1961; 134: 557-557.10.1126/science.134.3478.557
    Search in Google Scholar
  15. Morens DM, Pallansch MA. Epidemiology. In: Rotbart HA (ed) Human Enterovirus Infections. Washington DC ASM Press. 1995.
    Search in Google Scholar
  16. Nikolaeva L, Galabov AS. Synergistic inhibitory effect of enviroxime and disoxaril on poliovirus type 1 replication. Acta virol. 1995; 39: 235-241.
    Search in Google Scholar
  17. Nikolaeva L, Galabov AS. Cytotoxicity of the synergistic antienteroviral combination of enviroxime and disoxaril. Acta virol. 1999a; 43: 263-265.
    Search in Google Scholar
  18. Nikolaeva L, Galabov AS. In vitro inhibitory effects of dual combinations of picornavirus replication inhibittors. Acta virol. 1999b; 43: 303-311.
    Search in Google Scholar
  19. Nikolaeva L, Galabov AS. Antiviral effect of the combination of enviroxim and disoxaril on Coxsackievirus B1 infection. Acta virol. 2000; 44: 73-78.
    Search in Google Scholar
  20. Nikolaeva-Glomb L, Galabov AS. Synergistic drug combinations against the in vitro replication of Coxackie B1 virus. Antiviral Res. 2004; 16: 41-46.
    Search in Google Scholar
  21. Nikolova I, Galabov AS. Development of resistance to disoxaril in coxsackie B1 virus infected newborn mice. Antivir Res. 2003; 60: 35-40.10.1016/S0166-3542(03)00150-5
    Search in Google Scholar
  22. Pallansch M, Roos R. Enteroviruses: Polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. In: Knipe DM, Howley PM (ed) Fields Virology, Fifth Edition, Philadelphia, Lippincott Williams & Wilkins. 2006; pp. 895-910.
    Search in Google Scholar
  23. Pallansch MA. Enterovirus infections, including poliomyelitis. In: Guerrant RL, Walker DH, Weller PF (ed) Tropical Infectious Diseases. Principles, Pathogens and Practice. 3rd edn. 2011.10.1016/B978-0-7020-3935-5.00060-4
    Search in Google Scholar
  24. Prichard MN, Shipman CJr. A three-dimensional model to analyze drug-drug interactions. Antiviral Res. 1990; 14: 181-206.10.1016/0166-3542(90)90001-N
    Search in Google Scholar
  25. Rotbart HA, Webster AD. Treatment of potentially lifethreatening enterovirus infections with plrconaril. Clin Infect Dis. 2001; 32: 228-235.10.1086/318452
    Search in Google Scholar
  26. Schultheiss HP, Kuhl U. Overview on chronic viral cardiomyopathy/chronic myocarditis. Ernst Schering Res Found Workshop. 2006; 55: 3-18.10.1007/3-540-30822-9_1
    Search in Google Scholar
  27. Senior K. FDA panel rejects common cold treatment. Lancet Infect Dis. 2002; 2: 264.10.1016/S1473-3099(02)00277-3
    Search in Google Scholar
  28. Strauss J, Strauss E. Plus-Strand RNA Viruses. In: Viruses and Human Disease. 2008; pp 63-136.10.1016/B978-0-12-373741-0.50006-4
    Search in Google Scholar
  29. Tan W C. Viruses in asthma exacerbations. Current Opinion in Pulmonary Medicine. 2005; 11: 21-26.
    Search in Google Scholar
  30. Tauriainen S, Oikarinen S, Oikarinen M, Hyöty H. Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol. 2011; 33: 45-55.10.1007/s00281-010-0207-y20424841
    Search in Google Scholar
  31. Turner RB, Dutko FJ, Goldstein NH, Lockwood G, Hayden FG. Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection. Antimicrob Agents Chemother. 1993; 33: 2069-2074.10.1128/AAC.37.2.2971876568383943
    Search in Google Scholar
  32. Turner RB, Hendley O. Virucidal hand treatments for prevention of rhinovirus infection. J Antimicrob Chemother. 2005; 56: 805-807.10.1093/jac/dki32916159927
    Search in Google Scholar
  33. Vassileva-Pencheva R, Galabov AS. Avoiding drug-resistance development by novel approach of combining enteroviral substances against coxsackievirus B1 infection in mice. Antiviral Res. 2010; 85: 366-372.10.1016/j.antiviral.2009.11.00319900482
    Search in Google Scholar
DOI: https://doi.org/10.1515/prilozi-2015-0057 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 91 - 99
Published on: Dec 30, 2015
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
enteroviruses,
antivirals,
drug-resistance,
combination effects
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2015 Angel S. Galabov, Ivanka Nikolova, Ralitsa Vassileva-Pencheva, Adelina Stoyanova, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 36 (2015): Issue 2 (December 2015)Next article